Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaulov

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Mbio|March 10, 2021
Queuine Is a Nutritional Regulator of Entamoeba histolytica Response to Oxidative Stress and a Virulence AttenuatorShruti Nagaraja, Maggi W Cai, Jingjing Sun, et al.
Neuro-Oncology Advances|July 24, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade gliomaJian L Campian, Stuart A Grossman, Angela Shaulov Kask, et al.
Reproduction (Cambridge, England)|November 2, 2022
Immunomodulation for unexplained recurrent implantation failure: where are we now?Geneviève Genest, Shorooq Banjar, Walaa Almasri, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi SarcomaKathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
American Journal of Hematology|February 13, 2020
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working groupEirini Katodritou, Efstathios Kastritis, Moshe Gatt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaTarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
JCO Global Oncology|April 8, 2020
Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the GlobeAlexandra S Rashedi, Saskia F de Roo, Lauren M Ataman, et al.
JCO Global Oncology|April 8, 2020
Survey of Fertility Preservation Options Available to Patients With Cancer Around the GlobeAlexandra S Rashedi, Saskia F de Roo, Lauren M Ataman, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Mbio|March 10, 2021
Queuine Is a Nutritional Regulator of Entamoeba histolytica Response to Oxidative Stress and a Virulence AttenuatorShruti Nagaraja, Maggi W Cai, Jingjing Sun, et al.
Neuro-Oncology Advances|July 24, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade gliomaJian L Campian, Stuart A Grossman, Angela Shaulov Kask, et al.
Reproduction (Cambridge, England)|November 2, 2022
Immunomodulation for unexplained recurrent implantation failure: where are we now?Geneviève Genest, Shorooq Banjar, Walaa Almasri, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcomaRamya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi SarcomaKathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
American Journal of Hematology|February 13, 2020
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working groupEirini Katodritou, Efstathios Kastritis, Moshe Gatt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphomaTarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
JCO Global Oncology|April 8, 2020
Survey of Third-Party Parenting Options Associated With Fertility Preservation Available to Patients With Cancer Around the GlobeAlexandra S Rashedi, Saskia F de Roo, Lauren M Ataman, et al.
JCO Global Oncology|April 8, 2020
Survey of Fertility Preservation Options Available to Patients With Cancer Around the GlobeAlexandra S Rashedi, Saskia F de Roo, Lauren M Ataman, et al.
Pageof 16